Skip to main content
. 2019 Dec 21;25(47):6835–6846. doi: 10.3748/wjg.v25.i47.6835

Figure 3.

Figure 3

Overall survival by 5-year period of diagnosis of patients in Netherlands between 1989 and 2014. A: Patients with non-metastatic proximal esophageal cancer; B: Patients with metastatic proximal esophageal cancer. eP < 0.001 vs 1989-1994 group.